<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1393</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Imipenem-resistant Pseudomonas aeruginosa strains carry vim-type metallo-beta-lactamases isolated from intensive care unit, Shahid Beheshti Hospital, North of Iran</title>
	<subject_fa>ميکروبيولوژي</subject_fa>
	<subject>Microbiology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Pseudomonas aeruginosa is the causing agent of many hospital infections and metallo-beta-lactamases (MBL) are being reported with increasing frequency. The aim of this study was to determine the frequency of metallo-&amp;beta-lactamases (MBL) and VIM-1 gene in multidrug-resistant strains of &lt;i&gt;P. aeruginosa&lt;/i&gt; isolates and to compare the methods of phenotypic and molecular detection.&lt;br&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; In 2011- 2012, 50 samples of non &amp;ndash; duplicate &lt;i&gt;P. aeruginosa&lt;/i&gt; were isolated from intensive care units and tested for MBL production using phenotypic methods. Minimal Inhibitory concentrations (MICs) were determined by commercial micro dilution panels. The presence of metallo-&amp;beta-lactamase (MBL) genes was established by polymerase chain reaction (PCR) with specific primers targeting the bla (VIM) genes.&lt;br&gt;
&lt;b&gt;Results:&lt;/b&gt; We used 50 clinical isolates amongst which 18 (%36) were found resistant to imipenem. Productions of MBL were detected in 15 (30%) isolates applying phenotypic method. PCR assay showed that 9 (18%) isolates carried aVIM-1 gene. MBL- producing strains were shown 100% resistant to cefepime, ceftazidime, ceftriaxone, cefotaxime and imipenem. Amikacin and ofloxacin appeared to be the most active antimicrobial agent.&lt;br&gt;
&lt;b&gt;Conclusion:&lt;/b&gt; These findings demonstrate the emergence of bla (VIM-1) producing&lt;i&gt; P. aeruginosa&lt;/i&gt; in North of Iran. VIM metallo-beta-lactamases producing&lt;i&gt; P. aeruginosa&lt;/i&gt; strains can cause serious infections that are difficult to treat, therefore, there is a need for rapid identification and the timely implementation of infection control measures in combination with systematic surveillance to monitor its potential clonal spread.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Pseudomonas aeruginosa, metallo-beta-lactamases, Imipenem-resistant, bla (VIM-1) gene  </keyword>
	<start_page>28</start_page>
	<end_page>33</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-701-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Ramazan</first_name>
	<middle_name></middle_name>
	<last_name>Rajabiana</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Ramazan69@yahoo.com</email>
	<code>1</code>
	<orcid>10031947532846005890</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fariba</first_name>
	<middle_name></middle_name>
	<last_name>Asgharpour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>F_asgharpour@yahoo.com</email>
	<code>2</code>
	<orcid>10031947532846005891</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Para-Medicine; Babol University of Medical Sciences, Babol, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Moulana</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3</code>
	<orcid>10031947532846005892</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iranciences, Babol, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
